Eledon Pharmaceuticals, Inc.
Eledon Pharmaceuticals, Inc. (ELDN) Insider Trading
Form 4 buy vs sell counts, ratio, and sentiment — switch this quarter or last 12 months; chart and transactions below.
SEC EDGAR · FMP · ELDN · as of Jun 9, 2026
Activity summary
Buy transactions
3
P-Purchase only
Sell transactions
0
12 Months
Buy/Sell ratio
∞
Buy/Sell (by trades)
Overall sentiment
Eledon Pharmaceuticals, Inc. insiders have been net buyers of shares over the past 12 Months, which may signal confidence in the company's outlook.
▸ Source: SEC EDGAR · Form 3 & 4 · via Financial Modeling Prep · Buy = P-Purchase only · Sell = S-Sale only
As of Jun 9, 2026
ELDN insider buying and selling by quarter
ELDN insider selling · ELDN insider buying stocks · quarterly insider activity
Mobile shows last 4Q · Desktop shows full 8Q
▸ Source: SEC EDGAR · Form 3 & 4 · via Financial Modeling Prep · last 8 quarters
As of Jun 9, 2026
Active insiders
Most active in past 12 months · ELDN ceo insider trading
Showing all insiders · Click a card to filter the transactions table below
▸ Aggregated from reportingName · top 5 by trade count (12M) · no extra API
Recent insider transactions
ELDN executive sell shares · ELDN board member insider trading · ELDN insider trading SEC filing
Scroll horizontally to see all columns
| Date | Insider | Type | Shares | Value | Filing |
|---|---|---|---|---|---|
| Jan 10, 2026 | McBride John S. Director | Option | 3,430 | — | Form 4 |
| Jan 10, 2026 | Hillson Jan Director | Option | 3,430 | — | Form 4 |
| Jan 10, 2026 | Kirk Allan Director | Option | 3,430 | — | Form 4 |
| Jan 10, 2026 | Katkin Keith Director | Option | 8,575 | — | Form 4 |
| Jan 10, 2026 | Lee June Director | Option | 3,430 | — | Form 4 |
| Jan 10, 2026 | Robinson James A. Jr. Director | Option | 3,430 | — | Form 4 |
| May 1, 2023 | LYONS GARY A Director | Award | 150,437 | $346K | Form 4 |
| Nov 23, 2022 | Perrin Steven President | Purchase | 1,000 | $3K | Form 4 |
▸ Source: SEC EDGAR · Form 4 filings · ⚡ = value ≥ $1M · Award/Option price shows —
About ELDN insider trading
ELDN insider trades
Eledon Pharmaceuticals, Inc. (ELDN) insider trading data is sourced from SEC Form 4 filings submitted by corporate insiders, including McBride John S. (Director), Hillson Jan (Director), Kirk Allan (Director). Over the past 12 months, 5 insiders have filed transactions with the SEC. ELDN insiders have been primarily buying, which may reflect pre-scheduled Rule 10b5-1 plan executions.
For Eledon Pharmaceuticals, Inc.'s institutional ownership breakdown and insider ownership percentage, see the Ownership tab → Ownership tab →
Frequently asked questions
ELDN insider trading · 5 questionsThe insiders of Eledon Pharmaceuticals, Inc. (ELDN) include executives and directors such as McBride John S. (Director), Hillson Jan (Director), Kirk Allan (Director), among others. Over the past 12 months, 5 insiders have filed Form 4 transactions with the SEC. Insider transactions are required to be reported within 2 business days of the trade date.
▸ Source: FMP /stable/insider-trading/search · SEC EDGAR Form 3 & 4 · acquisitionOrDisposition A=Buy, D=Sell · RSU vesting (M-Exempt) excluded from sentiment bar · As of Jun 9, 2026